180 Participants Needed

Low Vision Rehabilitation + Emotion Regulation Therapy for Visual Impairment

JS
Overseen ByJessica Stout
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

The purpose of this study is to understand if combining Low Vision Rehabilitation (LVR) with Emotional Regulation Therapy (ERT) can help people with inherited retinal diseases (IRDs) that experience emotional distress related to participants' vision loss. The study team hypothesize that treatment with LVR will produce measurable functional gains and that these effects will be enhanced by ERT-linked improvement among the subgroup of IRD patients with elevated vision-related anxiety.

Will I have to stop taking my current medications?

The trial does not specify if you need to stop taking your current medications, but if you are on medication for mental health, you must be on a stable dose for at least one month to participate.

What data supports the effectiveness of the treatment Emotion Regulation Therapy (ERT) and Low Vision Rehabilitation (LVR) for visual impairment?

Research shows that emotion regulation therapy (ERT) can help improve emotional control in people with anxiety and depression, and similar therapies have been beneficial for emotional regulation in chronic diseases and cardiac rehabilitation. This suggests that ERT might also help people with visual impairment manage their emotions better.12345

Is Emotion Regulation Therapy (ERT) safe for humans?

Emotion Regulation Therapy (ERT) has been studied in various contexts, including anxiety and depression, and has shown positive outcomes without significant safety concerns reported in the available research.45678

How is the treatment of Low Vision Rehabilitation + Emotion Regulation Therapy for Visual Impairment different from other treatments?

This treatment is unique because it combines Low Vision Rehabilitation (LVR), which focuses on improving daily functioning for those with vision loss, with Emotion Regulation Therapy (ERT), which helps manage emotional responses. This dual approach addresses both the practical and emotional challenges of visual impairment, unlike traditional treatments that may focus solely on vision improvement.910111213

Research Team

KT

K. Thiran Jayasundera, MD, MS

Principal Investigator

University of Michigan

Eligibility Criteria

This trial is for individuals with inherited retinal diseases who are experiencing emotional distress due to vision loss. Participants should be emotionally distressed specifically because of their visual impairment.

Inclusion Criteria

I can attend 10 weeks of sessions in Michigan.
Have had a Goldmann visual field that was tested with III-4e isopter within the last year
Have a disability greater than zero theta in any of the domains of Michigan Retinal Dystrophy Questionnaire (MRDQ)
See 3 more

Exclusion Criteria

I am currently receiving treatment for a mental health condition.
The participant must not have an elevated suicidal intention (SI) or suicide risk based on Patient Health Questionnaire (PHQ-9) further information collected at screening (If suicidal intentions are identified, the study staff will complete the suicide protocol (per protocol)
My mental health medication dose has been stable for at least a month.
See 3 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive Low Vision Rehabilitation (LVR) and Emotional Regulation Therapy (ERT) based on their randomization group

6 months
Regular sessions as per therapy protocol

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

Treatment Details

Interventions

  • Emotion Regulation Therapy (ERT)
  • Low Vision Rehabilitation (LVR)
Trial OverviewThe study aims to determine if Low Vision Rehabilitation (LVR) combined with Emotion Regulation Therapy (ERT) can improve the well-being of patients with inherited retinal diseases and related emotional distress.
Participant Groups
3Treatment groups
Experimental Treatment
Active Control
Group I: Arm 3- LVR with delayed ERTExperimental Treatment2 Interventions
Participants with vision-related anxiety (must meet this per protocol by self-reports) randomized to this arm will receive LVR with delayed ERT.
Group II: Arm 2 - ERT (after randomization) and then concurrent with LVRExperimental Treatment2 Interventions
Participants with vision-related anxiety (must meet this per protocol by self-reports) randomized to this arm will receive immediate ERT. The LVR therapy will start approximately during 4-6 sessions of ERT.
Group III: Arm 1 - Low Vision Rehabilitation LVRActive Control1 Intervention
Participants (N \~ 60) without vision-related anxiety will be designated to Arm 1 and receive LVR. This group is intended to be a comparison for the higher vision-related anxiety groups. For this reason, these patients may be placed on a waitlist (meaning participants low-vision rehabilitation may be delayed), until the study team can match with someone in one of the other groups.

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Michigan

Lead Sponsor

Trials
1,891
Recruited
6,458,000+

National Eye Institute (NEI)

Collaborator

Trials
572
Recruited
1,320,000+

Findings from Research

In a study involving 150 adults with chronic illnesses, Mind-body and Art Therapies (MBATs) showed a slight improvement in emotional regulation skills, but the difference compared to the control group was not statistically significant.
No adverse effects were reported from the MBAT interventions, indicating they are safe for patients with chronic diseases, although the overall effectiveness in enhancing emotional regulation was only partially supported.
Mind-body and art therapies impact on emotional regulation in patients with chronic diseases: a pragmatic mixed-methods randomized controlled trial.Le Rhun, A., Caillet, P., Lebeaupin, M., et al.[2023]
Patients with acquired brain injury (ABI) take longer and generate fewer reappraisals for regulating emotions compared to healthy controls, indicating a potential challenge in emotion regulation after brain injury.
While ABI patients can effectively decrease the intensity of negative emotions, their ability to up-regulate neutral emotions to positive is less effective, suggesting specific deficits in emotion regulation strategies that could inform neuropsychological rehabilitation efforts.
Good things better? Reappraisal and discrete emotions in acquired brain injury.Rowlands, L., Coetzer, R., Turnbull, OH.[2021]
The RENEwS intervention, aimed at improving emotion regulation in cardiac rehabilitation patients, was found to be feasible, with 57% of the 14 participants completing the program.
Participants reported positive feedback on the intervention's acceptability and implementation, suggesting it could effectively support patients in managing their emotions to improve physical activity and reduce cardiovascular risks.
Feasibility of an Emotion Regulation Intervention for Patients in Cardiac Rehabilitation.Wierenga, KL., Fresco, DM., Alder, M., et al.[2022]

References

Mind-body and art therapies impact on emotional regulation in patients with chronic diseases: a pragmatic mixed-methods randomized controlled trial. [2023]
Good things better? Reappraisal and discrete emotions in acquired brain injury. [2021]
Feasibility of an Emotion Regulation Intervention for Patients in Cardiac Rehabilitation. [2022]
Emotion regulation after acquired brain injury: a study of heart rate variability, attentional control, and psychophysiology. [2020]
AN OPEN TRIAL OF EMOTION REGULATION THERAPY FOR GENERALIZED ANXIETY DISORDER AND COOCCURRING DEPRESSION. [2019]
Emotion Regulation Therapy for Generalized Anxiety Disorder. [2020]
Emo-regulator: An emotion-regulation training system fusing virtual reality and EEG-based neurofeedback. [2023]
Enhancing emotion regulation. [2023]
Interpretation of low-vision rehabilitation outcome measures. [2022]
Specialty level II fieldwork in low vision rehabilitation. [2013]
11.United Statespubmed.ncbi.nlm.nih.gov
Low Vision Rehabilitation, Age-Related Vision Loss, and Risk: A Critical Interpretive Synthesis. [2018]
State-of-the-art: low vision rehabilitation. [2022]
VA LOVIT II: a protocol to compare low vision rehabilitation and basic low vision. [2015]